ERISA Ledger · U.S. DOL EBSA Form 5500 (2023)

Galephar Pharmaceutical Research INC

Official 2023 U.S. DOL Form 5500 summary for Galephar Pharmaceutical Research INC (Galephar Pharmaceutical Retirement Plan · EIN 66-0965645 · PN 001): $222,035 net assets, 121 active participants, and $209.61 per $10,000 (209.61 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorGalephar Pharmaceutical Research INC
Filing IdentifierGalephar Pharmaceutical Retirement Plan · EIN 66-0965645 · PN 001
Plan Category & State401(k) Defined Contribution (PR)
Asset-Size Peer Cohort<$1M
Plan Net Assets (2023)$222,035
Active Participants121
Direct Admin Fee Rate$209.61 per $10,000 (209.61 bps)
Cohort Peer MedianN/A
Primary Recordkeeper / ProviderEmpower Retirement
Schedule H Line 4a RemittanceSchedule H Line 4a Late Remittance Reported ($26,458, often administrative timing)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI